The Neurobiological Effect of 5-HT2AR Modulation

NCT03289949 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Basic Science

Interventions

DRUG: Psilocybine
DRUG: Ketanserin

Sponsor

Gitte Moos Knudsen